NCT00027339 - Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2005

Conditions

HIV Infections

Interventions

DRUG

lopinavir/ritonavir

DRUG

indinavir sulfate

DRUG

tenofovir disoproxil fumarate

DRUG

ritonavir

DRUG

fosamprenavir

Trial Locations (14)

10003

Beth Israel Med. Ctr., ACTU, New York

10016

NY Univ. HIV/AIDS CRS, New York

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

37203

Vanderbilt Therapeutics CRS, Nashville

46202

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

80262

University of Colorado Hospital CRS, Aurora

92103

Ucsd, Avrc Crs, San Diego

95814

UC Davis Medical Center, Sacramento

275997215

Unc Aids Crs, Chapel Hill

Unknown

USC CRS, Los Angeles

Univ. of Miami AIDS CRS, Miami

94305-5107

Stanford CRS, Palo Alto

00936-5067

Puerto Rico-AIDS CRS, San Juan

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH